[Correspondence] Intravitreal aflibercept for proliferative diabetic retinopathy

We applaud the CLARITY study group for their efforts.1 We raise three issues aimed at a deeper understanding of the published data and its implications.

Source: LANCET - November 10, 2017 Category: General Medicine Authors: David M Brown, Charles C Wykoff Tags: Correspondence Source Type: research